Prevalence and Treatment of Pemphigus in Iran
References (18)
- et al.
Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris; possible common central Asian ancestral origin
Hum Immunol
(1997) - et al.
Randomized controlled open-label trial of 4 treatment regimens for pemphigus vulgaris
J Am Acad Dermatol
(2007) - et al.
Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial
J Invest Dermatol
(2010) - et al.
Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies
J Am Acad Dermatol
(2011) - et al.
A randomized double-blind trial of intravenous immunoglobulin for pemphigus
J Am Acad Dermatol
(2009) - Daneshpazhooh M, Chams-Davatchi C, Payandemehr P. Spectrum of autoimmune bullous diseases in Iran: a 10-year review....
- Chams-Davatchi C, Daneshpazhooh M, Esmaili N. Analysis of 1782 pemphigus. Presented at 21st World Congress of...
- et al.
HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris
J Clin Immunol
(2009) - et al.
Pemphigus: analysis of 1209 cases
Int J Dermatol
(2005)
There are more references available in the full text version of this article.
Cited by (11)
Serologic Biomarkers in Pemphigus Monitoring: C-reactive Protein, Macrophage Migration Inhibitory Factor, and Prolactin Levels Versus Autoantibody Assays
2023, Iranian Journal of Allergy, Asthma and ImmunologyModern diagnostics of autoimmune bullous diseases
2020, PathologeDiagnosis of autoimmune bullous diseases
2018, JDDG - Journal of the German Society of DermatologyDiagnosis of autoimmune bullous diseases
2018, JDDG - Journal of the German Society of DermatologyEpidemiological data of 290 pemphigus vulgaris patients: A 29-year retrospective study
2016, European Journal of Dermatology
Copyright © 2011 Elsevier Inc. All rights reserved.